Seattle Genetics

Contact
seattlegenetics.com
+1425527-4000

Seattle Genetics, Inc.

21823 - 30th Drive S.E.
98021 Bothell
USA
+1425527-4000
seattlegenetics.com
Contact
Profile News
Contact

About Seattle Genetics

Seattle Genetics is a clinical-stage biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease.

Read more about Seattle Genetics
Facts about Seattle Genetics
  • Focus : Manufacturer
  • Industry : Biotechnology

News about Seattle Genetics

Seattle Genetics

16-Sep-2020 | business & finance

Seattle Genetics and Merck & Co Announce Two Strategic Oncology Collaborations

Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock

Read news
Seattle Genetics

15-Sep-2011 | research and development

Seattle Genetics and Oxford BioTherapeutics to Collaborate on Antibody-Drug Conjugates for Cancer

Companies to combine proprietary technologies to generate novel ADC product candidates

Read news
Seattle Genetics

16-Sep-2010 | business & finance

Genmab and Seattle Genetics Enter Into Antibody-Drug Conjugate Research Collaboration

Genmab A/S and Seattle Genetics, Inc. announced that the companies have entered into an antibody-drug conjugate (ADC) research collaboration agreement. ...

Read news
Seattle Genetics

29-Sep-2004 | business & finance

Seattle Genetics Announces Antibody-Drug Conjugate Agreement with Bayer Pharmaceuticals

Bothell. Seattle Genetics, Inc. announced that Bayer Pharmaceuticals Corporation has licensed Seattle Genetics' proprietary antibody-drug conjugate (ADC) ...

Read news
Show more news about Seattle Genetics

Here you will find Seattle Genetics, Inc.